Skip to content

Bioequivalence study of two sulodexide preparations: Sulodexide Intexo 250 LRU and Vessel Due F 250 LRU cps

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515605-26-00
Acronym
SDX-CVU-FAST-001-24
Enrollment
20
Registered
2024-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition.

Interventions

None listed

Sponsors

Intexo Societa Benefit S.r.l.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026